ERAL1 and neoplasm: Further analysis of IL-10, CXCL10, and TGFβ (pro-tumor secreted markers) highlighted the functional repolarization of HERA-CD40L treated M2d macrophages, whereas Selicrelumab had no effect (Figure 4E).